Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7589193 C-aryl glucoside SGLT2 inhibitors and method

Patent 7589193 was granted and assigned to Bristol-Myers Squibb on September, 2009 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 16 Oct, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 16 Oct, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12115179 Pharmaceutical composition, methods for treating and uses thereof
0
Edits on 12 Mar, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 12 Mar, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11918596 Pharmaceutical composition, methods for treating and uses thereof
0
Edits on 7 Dec, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Dec, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11833166 Pharmaceutical composition, methods for treating and uses thereof
0
Edits on 17 Sep, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 17 Sep, 2023
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Wei Meng0
William Washburn0
Edits on 16 Sep, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 16 Sep, 2023
Edits made to:
Article (+42 characters)
Article

Patent abstract

A compound of the formula I

Edits on 15 Jul, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 15 Jul, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 07589193 C-aryl glucoside SGLT2 inhibitors and method US Patent 7589193 C-aryl glucoside SGLT2 inhibitors and method

Infobox
Patent Number
075891930
Patent Number
75891930
Edits on 21 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 21 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=075891930
Edits on 23 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 23 Sep, 2022
Infobox
Is a
Patent
Patent
0
Current Assignee
Bristol-Myers Squibb
Bristol-Myers Squibb
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
075891930
Date of Patent
September 15, 2009
0
Patent Application Number
112336170
Date Filed
September 23, 2005
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=075891930
Patent Primary Examiner
‌
Shaojia Anna Jiang
0
Edits on 18 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 18 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=07589193
Edits on 3 Dec, 2021
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 3 Dec, 2021
Edits made to:
Infobox (+8 properties)
‌

 US Patent 07589193 C-aryl glucoside SGLT2 inhibitors and method

Infobox
Is a
Patent
Patent
Current assignee
Bristol-Myers Squibb
Bristol-Myers Squibb
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
07589193
Date of patent
September 15, 2009
Patent application number
11233617
Date Filed
September 23, 2005
Patent primary examiner
‌
Shaojia Anna Jiang

Find more entities like US Patent 7589193 C-aryl glucoside SGLT2 inhibitors and method

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo